Original Research

Delayed remission following sequential infusion of humanized CD19- and CD22-modified CAR-T cells in a patient with relapsed/refractory acute lymphoblastic leukemia and prior exposure to murine-derived CD19-directed CAR-T cells

Yang F, Zhang J, Zhang X, Tian M, Wang J, Kang L, Qiu H, Wu D

OncoTargets and Therapy 2019, 12:2187-2191

Published Date: 25 March 2019